Z-LVG-CHN2

Overview

Z-LVG-CHN2 is a cell-permeable and irreversible inhibitor of cysteine proteinase . Z-LVG-CHN2 is a tripeptide derivative and mimics part of the human cysteine proteinase-binding center. Z-LVG-CHN2 displays an inhibition on HSV whereas no significant effect on poliovirus replication. Z-LVG-CHN2 effectively blocks SARS-COV-2 replication ( EC 50 =190 nM) via inhibition of SARS-COV-2 3CL pro protease.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Cathepsin | Products > Signaling Pathways > HSV | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-108137
• CAS No.: 119670-30-3
• Molecular Formula: C22H31N5O5
• Molecular Weight: 445.51
• Purity: 99.88%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (5.61 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source